ID
22550
Description
ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00350051
Link
https://clinicaltrials.gov/show/NCT00350051
Keywords
Versions (1)
- 6/7/17 6/7/17 -
Uploaded on
June 7, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostate Cancer NCT00350051
Eligibility Prostate Cancer NCT00350051
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Cytotoxic Chemotherapy Prostate carcinoma
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0677881
- UMLS CUI [1,2]
- C0600139
Description
Investigational New Drugs
Data type
boolean
Alias
- UMLS CUI [1]
- C0013230
Description
Brain Neoplasms Symptomatic | Radiotherapy to brain Patient need for
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0006118
- UMLS CUI [1,2]
- C0231220
- UMLS CUI [2,1]
- C0948319
- UMLS CUI [2,2]
- C0686904
Description
Communicable Disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
Exclusion Criteria Additional
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0680251
- UMLS CUI [1,2]
- C1524062
Similar models
Eligibility Prostate Cancer NCT00350051
- StudyEvent: Eligibility
C0332120 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2])
C1524062 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,2])
C0948319 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
C1524062 (UMLS CUI [1,2])